Literature DB >> 8931876

Arsenic induces interleukin-8 expression in cultured keratinocytes.

H T Yen1, L C Chiang, K H Wen, S F Chang, C C Tsai, C L Yu, H S Yu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931876     DOI: 10.1007/bf02505283

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  10 in total

1.  Progressive alterations of cytokeratin expressions in the process of chronic arsenism.

Authors:  H S Yu; K S Chiou; G S Chen; R C Yang; S F Chang
Journal:  J Dermatol       Date:  1993-12       Impact factor: 4.005

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells.

Authors:  C A Brenner; A W Tam; P A Nelson; E G Engleman; N Suzuki; K E Fry; J W Larrick
Journal:  Biotechniques       Date:  1989 Nov-Dec       Impact factor: 1.993

4.  Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ.

Authors:  R Gillitzer; R Berger; V Mielke; C Müller; K Wolff; G Stingl
Journal:  J Invest Dermatol       Date:  1991-07       Impact factor: 8.551

5.  Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8.

Authors:  N Mukaida; M Shiroo; K Matsushima
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

6.  IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.

Authors:  D Schadendorf; A Möller; B Algermissen; M Worm; M Sticherling; B M Czarnetzki
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

7.  Cytokine-induced gene expression of interleukin-8 in human transitional cell carcinomas and renal cell carcinomas.

Authors:  L V Abruzzo; A J Thornton; M Liebert; H B Grossman; H Evanoff; J Westwick; R M Strieter; S L Kunkel
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

8.  Interleukin-8 stimulates calcium transients and promotes epidermal cell proliferation.

Authors:  A Tuschil; C Lam; A Haslberger; I Lindley
Journal:  J Invest Dermatol       Date:  1992-09       Impact factor: 8.551

9.  The adenovirus E3 region 14.7 kDa protein, heat and sodium arsenite inhibit the TNF-induced release of arachidonic acid.

Authors:  D Zilli; C Voelkel-Johnson; T Skinner; S M Laster
Journal:  Biochem Biophys Res Commun       Date:  1992-10-15       Impact factor: 3.575

10.  Leukotriene B4 stimulates human polymorphonuclear leukocytes to synthesize and release interleukin-8 in vitro.

Authors:  R W McCain; E P Holden; T R Blackwell; J W Christman
Journal:  Am J Respir Cell Mol Biol       Date:  1994-06       Impact factor: 6.914

  10 in total
  4 in total

1.  Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells.

Authors:  C Escudero-Lourdes; T Wu; J M Camarillo; A J Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2011-10-10       Impact factor: 4.219

2.  Effects of arsenic on zebrafish innate immune system.

Authors:  Andrea C Hermann; Carol H Kim
Journal:  Mar Biotechnol (NY)       Date:  2005-07-05       Impact factor: 3.619

3.  Sodium arsenite-induced stress-related gene expression in normal human epidermal, HaCaT, and HEL30 keratinocytes.

Authors:  Kevin J Trouba; Kristen M Geisenhoffer; Dori R Germolec
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

4.  Characterization of gene expression changes associated with MNNG, arsenic, or metal mixture treatment in human keratinocytes: application of cDNA microarray technology.

Authors:  Dong-Soon Bae; William H Hanneman; Raymond S H Yang; Julie A Campain
Journal:  Environ Health Perspect       Date:  2002-12       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.